Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) has great potential in the treatment of Alzheimer’s disease and special focus has been directed to these targets. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.